...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
【24h】

Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.

机译:新型exo-亚甲基环戊酮四环二萜类化合物作为抗肿瘤剂的合成及生物学评价。

获取原文
获取原文并翻译 | 示例
           

摘要

The structure of exo-methylene cyclopentanone, which exists in nature tetracyclic diterpenoids products, has been proved to be an innate group for the treatment of cancer and inflammation. In this letter, four different scaffolds of tetracyclic diterpenoids including the structure exo-methylene cyclopentanone were synthesized from steviol and isosteviol and evaluated in vitro for their antitumor activity against three human cancer lines. Compounds 1a, 1b, 2b and 3b showed significant cytotoxicity, particularly, tetracyclic diterpenoids 2b, 3b were identified as the most potent and selective anticancer agents superior to adriamycin with IC(50) values of 0.9 muM and 1.5 muM, against Hep-G2 and MDA-MB-231 cell lines, respectively.
机译:自然界中存在的四环二萜类化合物中存在的外亚甲基环戊酮的结构已被证明是治疗癌症和炎症的先天基团。在这封信中,从甜菊醇和异osteviol合成了四个不同的四环二萜类支架,包括exo-亚甲基环戊酮结构,并在体外评估了它们对三种人类癌症系的抗肿瘤活性。化合物1a,1b,2b和3b具有明显的细胞毒性,特别是四环二萜类化合物2b,3b被确定为最强和选择性的抗癌剂,对Hep-G2和Hp-G2的IC(50)值为0.9μM和1.5μM。 MDA-MB-231细胞株分别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号